We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tissue Properties Should Direct Breast Implant Selection

By HospiMedica International staff writers
Posted on 11 Nov 2016
A new study concludes that tissue-based planning (TBP) is the superior approach to primary breast augmentation implant size selection.

Researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, USA) and McMaster University (Hamilton, Canada) conducted a literature review of the methods used by plastic surgeons to select the appropriate implant size for primary breast augmentation surgery. More...
The implant size selection systems were divided into three groups:

• Implants chosen based solely on the patient's or surgeon's preference.
• Implants chosen using dimensional analysis systems in order to establish a desired result.
• Implants chosen using TBP, with measurements used to set clear boundaries for implant selection based on clinical guidelines, with limited to no flexibility.

The researchers reported that while 33 implant size selection systems were included in the final analysis, only four reported clinical outcomes that could be compared to accepted literature values or industry standards. The articles that described TBP systems were of highest methodologic quality, when compared to those that stressed desire of the patient and/or surgeon, and those that did not use breast measurement. The study was published in the November 2016 issue of Plastic and Reconstructive Surgery.

“The top ten studies based on methodological quality all used patients' breast dimensions before selecting final implant dimensions, and this should now be considered standard of practice based on our analysis,” concluded study authors William Adams Jr. MD, and Daniel Mckee, MD. “Going forward, new published systems should use rigorous quantitative methods so that comparisons can be made in terms of patient outcomes.”

A breast implant is a prosthesis used to change the size, shape, and contour of a woman’s breast. There are three general types of breast implantw, defined by their filler - saline solution, silicone gel, and composite filler. The saline implant has an elastomer silicone shell filled with sterile saline solution during surgery; the silicone implant has an elastomer silicone shell pre-filled with viscous silicone gel; and the alternative composition implants featured miscellaneous fillers, such as soy oil, polypropylene string, etc. Composite implants are banned in the United States and Europe due to associated health risks and complications.

Related Links:
University of Texas (UT) Southwestern Medical Center
McMaster University

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Portable Jaundice Management Device
Nymphaea
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.